RxSpan MD review

RxSpan MD presents itself as a physician-led telehealth platform covering weight loss, longevity, sexual health and hair loss. That makes it relevant to someone comparing peptide care with a wider wellness discussion rather than looking only for a GLP-1 subscription. The homepage identifies John Diaz as its founder and describes clinician review before prescribing. Those statements explain how the service is presented; they do not establish who will handle your individual appointment or what treatment you will receive. Ask for the assigned medical practice, clinician and follow-up process. The Strut Health review offers another broad-menu comparison. Choose between platforms by the actual care offered for your condition, including the ability to ask questions and obtain a treatment explanation, rather than by the number of categories available in the navigation.

The current weight-loss page distinguishes compounded semaglutide and tirzepatide from branded Wegovy, Ozempic and Zepbound. It also describes oral capsules as well as injectable compounded preparations. These distinctions deserve more attention than a single ingredient name: an oral capsule is not automatically equivalent to an approved injection or another oral product. Ask for the exact active ingredient, added ingredients, route and dispensing pharmacy, then ask what evidence supports the proposed preparation. The page’s own calculator notes that its outcome estimates come from approved-drug trials rather than studies of each compounded formulation. The GLP-1 product identity guide explains why that qualification matters. A product comparison can help structure a conversation, but it cannot predict your response or establish that every preparation has the same evidence.

The commercial decision needs a current written quote. Earlier published offers do not establish a current quote, and the current product listing returns an incomplete product display in a text-accessible view. Numeric comparison prices are therefore withheld. That does not prove the clinic has stopped offering treatment; it does mean a reader should confirm current availability and price directly. Do not use an older plan figure as a promise of what you can buy today. Ask how much is charged before consultation, what happens if the requested prescription is declined, and whether a longer plan is prepaid or automatically renewed. The treatment quote checklist helps compare the first payment with the ordinary renewal and total commitment. The short public terms require payment for services but do not provide a detailed unused-balance refund formula, so request that answer before committing funds.

RxSpan MD’s telehealth consent allows video, messaging and questionnaires. It also acknowledges that remote communication can leave information incomplete or delay evaluation. Ask whether your initial assessment will be live, what records the clinician needs and when an in-person examination would be appropriate. For longevity care, start with a specific question rather than a broad goal such as feeling younger. The homepage advertises NAD+, sermorelin and glutathione, but those names do not settle the proposed form, reason for treatment or monitoring. The sermorelin evidence discussion and NAD+ evidence discussion can help you prepare questions. Ask what measurable benefit would justify continuing and how the clinician would decide that a treatment is not helping. Membership convenience should complement a clear clinical rationale.

Pharmacy identity remains a separate part of the comparison. The pharmacy check below carries a Flag from the underlying evidence; it should not be read as approval of every facility associated with the platform. Obtain the exact location assigned to your prescription and compare the name and address with the label that arrives. A network relationship alone does not establish authorization to dispense to your address. The pharmacy framework guide explains why the preparation and dispensing facility both matter. For compounded GLP-1 treatment, FDA recommends using these products only when a patient’s needs cannot be met by an approved drug. Ask the prescriber to address that patient-specific question, and ask who handles storage concerns, shipping problems and clinical symptoms after delivery. A complete answer should cover care after the sale as clearly as the intake.